News/Events
Cambridge begins world-first COVID-19 vaccine booster study
Researchers in Cambridge have welcomed their first participants in a new UK study to understand the effects of a ‘booster’ dose of a COVID-19 vaccine.Read more
A single gene could be the reason why some of us carry an extra 30 pounds of fat
New research has found that one in every 340 people might carry a mutation in a single gene that makes them more likely to carry extra weight. Read more
World-first covid-19 vaccine booster study launches in Eastern region
Volunteers from the East of England will soon be able to receive a third ‘booster’ COVID-19 vaccine through a new Government-funded clinical trial.Read more
Join us in supporting International Clinical Trials Day
Every year 20 May is celebrated by healthcare workers, researchers, patients and communities around the world to mark International Clinical Trials Day.
On this day in 1747, ship surgeon James Lind started what Read more
IBD BioResource – Celebrating 5 years of its contribution to Crohn’s and Colitis research
The NIHR IBD BioResource marks their fifth year of helping to transform the research in Crohn’s disease and ulcerative colitis. Read more
Cambridge clinical researchers elected Fellows of the Royal Society
Two NIHR Cambridge BRC clinical researchers, Prof. Sadaf Farooqi and Prof. David Rowitch, have been elected as Royal Society Fellows.Read more
Save your energy! New tool shows algorithms’ environmental impact
Data science and artificial intelligence are transforming UK healthcare – but at an environmental cost.
The data centres housing the supercomputers that run the algorithms account for 100 megatonnes of CO2 emissions every Read more
Ability of multi-drug resistant infection to evolve within cystic fibrosis patients highlights need for rapid treatment
Researchers have tracked how a multi-drug resistant organism is able to evolve and spread widely among cystic fibrosis patients Read more
Differing immune responses discovered in asymptomatic cases and those with severe COVID-19
A UK-wide study part-funded by the NIHR has identified differences in people’s immune responses to COVID-19, depending on whether they have no symptoms or more serious reactions to the virus.Read more
Stress does not lead to loss of self-control in eating disorders, study finds
Stress does not trigger binge eating in people with eating disorders, new research suggests.Read more
Placenta is dumping ground for genetic defects
Researchers have confirmed that the normal structure of the placenta is different to any other human organ and resembles that of a tumour, harbouring many of the same genetic mutations found in childhood cancers.Read more
Diphtheria risks becoming ‘major global threat’ again as it evolves resistance to antimicrobials
Diphtheria is evolving to become resistant to a number of classes of antibiotics and in future could lead to vaccine escape, warn an international team of researchers.Read more
Celebrating International Women’s Day
8th March marks International Women’s Day, hear from two women who work in research at the NIHR Cambridge Biomedical Research Centre.Read more
Genomics study identifies routes of transmission of coronavirus in care homes
Genomic surveillance – using information about genetic differences between virus samples – can help identify how SARS-CoV-2 spreads in care home settings.Read more
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
New data suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.Read more
Can a tapeworm drug boost protection from Covid-19 for high-risk kidney patients?
A new trial led by Cambridge launches to see if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high-risk kidney patients.Read more
Could repairing damaged donor livers be the key to increasing life-saving transplants?
Researchers have found a way to grow ‘mini bile ducts’ in a lab-setting to repair damaged livers.Read more
Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2
The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy is modestly affected. However, when the E484K mutation – first seen in the South African variant – is added, it substantially increases the amount of antibody required to prevent infection.Read more
New research suggests COVID-19 severity can be predicted in hospitalised patients
Research conducted at Addenbrooke’s hospital and supported by the NIHR Cambridge Biomedical Research Centre has found it may be possible to predict which patients will go on to develop severe or long-term COVID Read more
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.Read more
Discover more about the NIHR Cambridge BRC
Contact us by phone, email or web for more information.
Events Calendar
Listing relevant events and training sessions for researchers and members of the public.